Portfolio in Urology

About Syner-Med

Syner-Med is a private, UK-based biopharmaceutical company founded in 2018, specializing in the late-stage development and commercialization of medicines and medical devices. Its business model centers on in-licensing assets and advancing them through clinical development and regulatory approval, primarily within the Vascular Access, Urology, and Urogynaecology sectors. The company appears to be in a commercial or near-commercial stage, generating revenue through its marketed products and partnerships. Its strategy is heavily reliant on establishing international distribution networks to reach global healthcare markets.

Therapeutic Areas

Other Urological conditions Drugs